Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


22.07.2019

1 Acta Neurol Scand
1 BMC Neurol
1 Brain
3 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
2 Lancet Neurol
1 Mayo Clin Proc
2 Mult Scler
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life use of oral disease-modifying treatments in Austria.
    Acta Neurol Scand. 2019;140:32-39.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. BANSBACK N, Chiu JA, Carruthers R, Metcalfe R, et al
    Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
    BMC Neurol. 2019;19:173.
    PubMed     Text format     Abstract available


    Brain

  3. WENTLING M, Lopez-Gomez C, Park HJ, Amatruda M, et al
    A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
    Brain. 2019 Jul 15. pii: 5531715. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurol

  4. RAIMO S, Trojano L, Gaita M, Spitaleri D, et al
    High openness and high extroversion are linked with better time-based prospective memory in multiple sclerosis.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09460.
    PubMed     Text format     Abstract available

  5. MICHAEL G, Christian E, Fritz L, Jorg K, et al
    Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09464.
    PubMed     Text format     Abstract available

  6. MO XB, Lei SF, Qian QY, Guo YF, et al
    Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.
    J Neurol. 2019 Jul 18. pii: 10.1007/s00415-019-09476.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  7. COCCO E
    Getting older, getting worse: menopause as a turning-point for women living with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2019 Jul 17. pii: jnnp-2019-321121.
    PubMed     Text format    


    J Neurol Sci

  8. BATCHELLER L, Baker D
    Cost of disease modifying therapies for multiple sclerosis: Is front-loading the answer?
    J Neurol Sci. 2019;404:19-28.
    PubMed     Text format     Abstract available


    Lancet Neurol

  9. PLOUGHMAN M
    Restoring function in progressive multiple sclerosis.
    Lancet Neurol. 2019;18:711-712.
    PubMed     Text format    

  10. FREEMAN J, Hendrie W, Jarrett L, Hawton A, et al
    Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
    Lancet Neurol. 2019;18:736-747.
    PubMed     Text format     Abstract available


    Mayo Clin Proc

  11. SAVOLDI F, Nasr Z, Hu W, Schilaty ND, et al
    McArdle Sign: A Specific Sign of Multiple Sclerosis.
    Mayo Clin Proc. 2019 Jul 11. pii: S0025-6196(19)30219.
    PubMed     Text format     Abstract available


    Mult Scler

  12. HACOHEN Y, Brownlee W, Mankad K, Chong WK', et al
    Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.
    Mult Scler. 2019 Jul 18:1352458519863781. doi: 10.1177/1352458519863781.
    PubMed     Text format     Abstract available

  13. CAMARA-LEMARROY CR, Silva C, Greenfield J, Liu WQ, et al
    Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.
    Mult Scler. 2019 Jul 18:1352458519863133. doi: 10.1177/1352458519863133.
    PubMed     Text format     Abstract available


    PLoS One

  14. VAZQUEZ-MARRUFO M, Galvao-Carmona A, Caballero-Diaz R, Borges M, et al
    Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    PLoS One. 2019;14:e0219594.
    PubMed     Text format     Abstract available

  15. RO LS, Yang CC, Lyu RK, Lin KP, et al
    A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan.
    PLoS One. 2019;14:e0202453.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: